AMPLI Fundamental Analysis - AMPLITUDE SURGICAL SAS

Fundamental Rating

Overall AMPLI gets a fundamental rating of 2 out of 10. We evaluated AMPLI against 57 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of AMPLI while its profitability can be described as average. AMPLI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

AMPLI had positive earnings in the past year.

In the past year AMPLI had a positive cash flow from operations.

In multiple years AMPLI reported negative net income over the last 5 years.

AMPLI had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of 0.39%, AMPLI is not doing good in the industry: 63.16% of the companies in the same industry are doing better.

AMPLI has a worse Return On Equity (1.15%) than 63.16% of its industry peers.

AMPLI's Return On Invested Capital of 3.48% is on the low side compared to the rest of the industry. AMPLI is outperformed by 63.16% of its industry peers.

AMPLI had an Average Return On Invested Capital over the past 3 years of 2.94%. This is significantly below the industry average of 8.81%.

The 3 year average ROIC (2.94%) for AMPLI is below the current ROIC(3.48%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	0.39%
ROE	1.15%
ROIC	3.48%

ROA(3y)4.54%

ROA(5y)0.64%

ROE(3y)11.48%

ROE(5y)-1.81%

ROIC(3y)2.94%

ROIC(5y)N/A

1.3 Margins

AMPLI has a Profit Margin (1.00%) which is in line with its industry peers.

Looking at the Operating Margin, with a value of 10.22%, AMPLI is in line with its industry, outperforming 52.63% of the companies in the same industry.

AMPLI has a better Gross Margin (79.74%) than 91.23% of its industry peers.

In the last couple of years the Gross Margin of AMPLI has grown nicely.

		Industry Rank	Sector Rank
OM	10.22%
PM (TTM)	1%
GM	79.74%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.67%

GM growth 5Y9.09%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMPLI is destroying value.

AMPLI has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for AMPLI has been increased compared to 5 years ago.

Compared to 1 year ago, AMPLI has a worse debt to assets ratio.

2.2 Solvency

AMPLI has an Altman-Z score of 1.41. This is a bad value and indicates that AMPLI is not financially healthy and even has some risk of bankruptcy.

AMPLI has a worse Altman-Z score (1.41) than 63.16% of its industry peers.

AMPLI has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.

AMPLI has a Debt to Equity ratio of 1.11. This is amonst the worse of the industry: AMPLI underperforms 82.46% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.11
Debt/FCF	N/A
Altman-Z	1.41

ROIC/WACC0.51

WACC6.85%

2.3 Liquidity

AMPLI has a Current Ratio of 1.91. This is a normal value and indicates that AMPLI is financially healthy and should not expect problems in meeting its short term obligations.

With a Current ratio value of 1.91, AMPLI perfoms like the industry average, outperforming 59.65% of the companies in the same industry.

A Quick Ratio of 0.94 indicates that AMPLI may have some problems paying its short term obligations.

AMPLI has a Quick ratio (0.94) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.91
Quick Ratio	0.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AMPLI have decreased strongly by -97.47% in the last year.

AMPLI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.25%.

Measured over the past years, AMPLI shows a small growth in Revenue. The Revenue has been growing by 0.67% on average per year.

EPS 1Y (TTM)-97.47%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-245.95%

Revenue 1Y (TTM)4.25%

Revenue growth 3Y8.63%

Revenue growth 5Y0.67%

Sales Q2Q%4.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AMPLI is valuated quite expensively with a Price/Earnings ratio of 312.50.

The rest of the industry has a similar Price/Earnings ratio as AMPLI.

AMPLI is valuated expensively when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	312.5
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMPLI is valued a bit cheaper than 61.40% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	15.95

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AMPLI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMPLITUDE SURGICAL SAS

EPA:AMPLI (9/4/2025, 7:00:00 PM)

6.25

+0.05 (+0.81%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)04-17 2025-04-17

Earnings (Next)10-22 2025-10-22

Inst Owners0.11%

Inst Owner ChangeN/A

Ins Owners0.26%

Ins Owner ChangeN/A

Market Cap300.13M

Analysts40

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	312.5
Fwd PE	N/A
P/S	2.77
P/FCF	N/A
P/OCF	50.58
P/B	3.17
P/tB	N/A
EV/EBITDA	15.95

EPS(TTM)0.02

EY0.32%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.27

FCFYN/A

OCF(TTM)0.12

OCFY1.98%

SpS2.26

BVpS1.97

TBVpS-0.86

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	0.39%
ROE	1.15%
ROCE	4.78%
ROIC	3.48%
ROICexc	3.8%
ROICexgc	10.4%
OM	10.22%
PM (TTM)	1%
GM	79.74%
FCFM	N/A

ROA(3y)4.54%

ROA(5y)0.64%

ROE(3y)11.48%

ROE(5y)-1.81%

ROIC(3y)2.94%

ROIC(5y)N/A

ROICexc(3y)3.37%

ROICexc(5y)N/A

ROICexgc(3y)9.91%

ROICexgc(5y)N/A

ROCE(3y)4.01%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.67%

GM growth 5Y9.09%

F-Score7

Asset Turnover0.39

Health

		Industry Rank	Sector Rank
Debt/Equity	1.11
Debt/FCF	N/A
Debt/EBITDA	4.25
Cap/Depr	137.68%
Cap/Sales	17.25%
Interest Coverage	250
Cash Conversion	24.04%
Profit Quality	N/A
Current Ratio	1.91
Quick Ratio	0.94
Altman-Z	1.41

F-Score7

WACC6.85%

ROIC/WACC0.51

Cap/Depr(3y)129.83%

Cap/Depr(5y)100.73%

Cap/Sales(3y)17.03%

Cap/Sales(5y)14.71%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-97.47%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-245.95%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)4.25%

Revenue growth 3Y8.63%

Revenue growth 5Y0.67%

Sales Q2Q%4.99%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y26.79%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-25.25%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-18.6%

OCF growth 3Y19.93%

OCF growth 5Y-13.28%

AMPLITUDE SURGICAL SAS (AMPLI.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens